bmi required for glp 1 GLP1-Injections GLP-1

We saw the same issues with compounded semaglutide and tirzepatide

Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, et al

2018 DOI: 10.1016/j.molmet.2018.09.009 PMID: 30473097 Read on PubMed

Table 1 Baseline characteristics of participants in case and control groups across each SUD cohort

Notably, semaglutide at 2.4 mg and tirzepatide at a dose of 1015 mg administered weekly have shown significant weight reductions exceeding 10% in clinical trials among non-diabetic individuals

Patients who still prefer non-surgical care can absolutely pursue it, but only if expectations match what the technology can realistically deliver